Synthesis of Novel 2-(Isopropylamino)thiazol-4(5H)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and

Daria Kupczyk1, Renata Studzińska2, Rafał Bilski1

  • 1Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-092 Bydgoszcz, Poland.

Insights

Novel thiazolone derivatives show promise as cancer therapeutics by inhibiting 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes involved in glucocorticoid metabolism and tumor growth.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Oncology

Background:

  • Tissue-level glucocorticoid metabolism is controlled by 11β-hydroxysteroid dehydrogenase (11β-HSD) isoenzymes, interconverting cortisol and cortisone.
  • 11β-HSD1 and 11β-HSD2 are implicated as autocrine factors in tumor cell proliferation and differentiation.
  • Targeting these enzymes presents a potential strategy for anti-cancer therapy.

Purpose of the Study:

  • To synthesize novel 2-(isopropylamino)thiazol-4(5H)-one derivatives.
  • To evaluate the inhibitory activity and selectivity of these derivatives against 11β-HSD1 and 11β-HSD2.

Main Methods:

  • Synthesis of novel 2-(isopropylamino)thiazol-4(5H)-one derivatives.
  • In vitro assessment of enzyme inhibition for 11β-HSD1 and 11β-HSD2.
  • Determination of compound selectivity for each isoenzyme.

Main Results:

  • A spirocyclic thiazole-cyclohexane derivative exhibited the highest 11β-HSD1 inhibition (54.53% at 10 µM) and selectivity.
  • Derivatives with ethyl and n-propyl groups at C-5 of the thiazole ring showed significant 11β-HSD2 inhibition (47.08% and 54.59% at 10 µM, respectively) with complete selectivity.
  • These findings highlight specific structure-activity relationships for 11β-HSD inhibition.

Conclusions:

  • The synthesized thiazolone derivatives demonstrate potent and selective inhibition of 11β-HSD1 and 11β-HSD2.
  • Modulating 11β-HSD activity through these compounds may impact tumor formation and progression.
  • These novel derivatives hold potential as adjunctive pharmaceuticals in anti-cancer therapy.